Skin cancer types: Squamous cell carcinoma treatment
Skin cancer: Squamous cell carcinoma treatment
Squamous cell carcinoma is highly treatable when found early
Found early, a dermatologist can often treat squamous cell carcinoma of the skin cancer in the office.
How do dermatologists diagnose squamous cell carcinoma of the skin?
Because this cancer begins on the skin, it’s possible to find it early when it’s highly treatable.
When you see a board-certified dermatologist, your dermatologist will examine your skin carefully.
If your dermatologist finds a spot on your skin that could be any type of skin cancer, your dermatologist will first numb the area and then remove all (or part) of it. This can be done during an office visit and is called a skin biopsy. This is a simple procedure, which a dermatologist can quickly, safely, and easily perform.
Having a skin biopsy is the only way to know for sure whether you have skin cancer.
What your dermatologist removes will be examined under a high-powered microscope. Your dermatologist or a doctor who has in-depth experience diagnosing skin growths, such as a dermatopathologist, is best qualified to examine the removed tissue under a microscope.
After examining the removed tissue, the doctor writes a biopsy report. Also called a pathology report, this report explains what was seen under the microscope, including whether any skin cancer cells were seen.
If you have squamous cell carcinoma (SCC) of the skin, the report will contain the following information when possible:
Type of SCC
Stage of the cancer
Whether the cancer has any features that make it aggressive
How do dermatologists treat squamous cell carcinoma of the skin?
Most patients are treated with a type of surgery called surgical removal. Your dermatologist or Mohs surgeon can often perform this type of treatment during an office visit.
The following describes what to expect from surgical removal and other treatments for this skin cancer:
Surgical removal: Three types of surgical removal are used to treat this type of skin cancer. All can be performed during an office visit while you remain awake.
Your dermatologist will choose the type of surgical removal you receive, based on where the skin cancer appears on your body, how deeply the cancer has grown, and other considerations.
During surgical removal, your dermatologist cuts out the tumor. When the cancer is caught early, this may be the only treatment you need.
Here's what happens during each type of surgical removal used to treat this skin cancer:
Excision: The area to be treated is first numbed. Next, your dermatologist cuts out the tumor along with an area of normal-looking skin. Removing some normal-looking skin helps to get rid of stray cancer cells.
What your dermatologist removes will be looked at under a high-powered microscope by a specially trained doctor, such as a dermatopathologist or pathologist. If the doctor does not see cancer cells in the normal-looking skin, your treatment is complete.
When cancer cells are found in the normal-looking skin, you need more treatment. Often this means more excision. For some patients, another type of treatment may be more appropriate.
Mohs (rhymes with nose) surgery: This surgery is often used to treat SCC skin cancer because many of these cancers develop on the face, neck, or hand. Mohs surgery allows the surgeon to remove the least amount of tissue required to treat the cancer.
During Mohs surgery, you remain awake while the surgeon removes one layer of tissue and then examines it under a microscope. This process continues until the surgeon no longer sees cancer cells.
To learn more about what’s involved in having Mohs surgery and when it’s recommended, go to, What is Mohs surgery?
Curettage and electrodessication: During this type of surgical removal, your dermatologist first scrapes the tumor from your skin, using a technique called curetting. Next, your dermatologist applies an electrode to destroy remaining cancer cells.
A dermatologist may use this procedure to treat a small SCC that is classified as a low-risk tumor. Dermatologists do not use this surgery to treat skin cancer on areas of the body where hair grows heavily, such as the scalp, a man’s beard area, or an armpit.
Radiation therapy: If surgical removal alone cannot treat the cancer or you cannot have surgical removal, your treatment plan may include radiation treatments.
The different types of radiation therapy used to treat SCC are:
Superficial radiation therapy: Beams of radiation are directed just beneath the skin, which treats only the tumor.
External beam radiation therapy: High-energy beams of radiation are sent into the tumor in order to kill cancer cells.
Brachytherapy (bray-key-ther-uh-pee): Radioactive implants are placed inside (or near) the cancer. Also called internal radiation, this therapy is often used to treat prostate cancer.
Radiation therapy may be given as a second type of treatment when there is a high risk that the cancer will spread. In this case, radiation therapy often follows surgical removal.
If the skin cancer has grown deep or spread, radiation therapy may help a patient feel more comfortable.
Cryosurgery: This treatment involves using an extremely cold substance, such as liquid nitrogen, to destroy the cancer cells. Although seldom used to treat SCC, cryotherapy can be an option when the cancer is caught early, or a patient cannot have any type of surgical removal.
Clinical trial: This is a research study. It helps doctors find better treatments for cancer and other diseases. Patients who participate in a clinical trial do so voluntarily. Your dermatologist may recommend that you consider a clinical trial if the treatment could produce the best results for you.
While your dermatologist may recommend a clinical trial, you make the final decision about whether to participate.
Observation: For some patients, observation may be recommended. Observation means that your dermatologist will watch your cancer over time and only consider treatment if the cancer worsens.
This may be an option for an elderly patient who has a slow-growing SCC.
Palliative care: Rather than treat the cancer, this care offers relief from the symptoms or stress of having cancer.
How is squamous cell carcinoma of the skin treated when it spreads?
When this cancer spreads beyond the skin, it travels to the lymph nodes or other organs. Once it spreads, a patient has advanced cancer.
If you've been diagnosed with advanced SCC, you will be cared for by a team of medical professionals. This team will include oncologists (cancer doctors). Your treatment plan may include one or more of the following:
Surgery: When surgery can remove the cancer and you’re healthy enough to have surgery, this is often the preferred treatment. After surgery, another treatment, such as radiation therapy or chemotherapy, is often given. Adding another treatment helps to kill cancer cells.
Radiation therapy: Radiation can target cancer cells in the skin, lymph nodes, or other areas of the body. When a patient has advanced SCC, radiation therapy is often used along with another treatment.
Immunotherapy: This type of treatment helps strengthen your immune system so that it can fight the cancer. Drugs called immunotherapy medications are given for this purpose.
The U.S. Food and Drug Administration (FDA) has approved one immunotherapy medication for the treatment of advanced SCC of the skin. It’s called cemiplimab-rwlc.
In the clinical trials that led the FDA to approve cemiplimab-rwlc, about half the patients who had advanced SCC of the skin had their tumors shrink. In many patients who had tumor shrinkage, the shrinking lasted 6 months or longer. A few patients had their tumors disappear completely.
Cemiplimab-rwlc is given by an intravenous (IV) infusion, which is also known as an IV drip. The infusion for cemiplimab-rwlc usually takes about 30 minutes. Most patients go to a hospital or cancer treatment center once every 3 weeks to receive this infusion.
Patients usually receive immunotherapy medication through infusion therapy, which is also called an IV drip.
Another immunotherapy medication may be more appropriate for you. Pembrolizumab is another such medication given to treat advanced SCC of the skin. In clinical trials, pembrolizumab is showing promise.
Pembrolizumab is also given by IV infusion.
Like all medications, immunotherapy drugs are not right for every patient. Because immunotherapy medication changes the way your immune system works, some side effects from these medications can be serious.
Your doctor can tell you whether immunotherapy medication may be an option for you. If this is an option, you may receive only immunotherapy medication or be given this medication along with other cancer treatment.
Chemotherapy: This treatment can help slow the spreading cancer and relieve symptoms. Sometimes, it shrinks tumors.
There are many different chemotherapy drugs. The ones used to treat advanced SCC are usually given by an IV drip.
Chemotherapy drugs work by killing fast-growing cells in the body. Cancer cells are just one type of cell that grows quickly. Hair cells and cells in your gastrointestinal (GI) tract also grow quickly and can be killed. When chemotherapy kills these cells, patients develop side effects, such as hair loss and nausea.
Other treatments for advanced SCC of the skin: No single treatment is best for everyone who has this advanced cancer. Your medical team will consider your unique needs. Another type of treatment may be recommended.
What is the outlook for someone who has squamous cell carcinoma of the skin?
When found early, this cancer is highly treatable. Left untreated, however, SCC can spread deep into the skin and travel to other parts of the body, making treatment difficult.
While treatment can remove the cancer, it’s important to know that this cancer can return. You also have a greater risk of developing another skin cancer.
That’s why self-care becomes so important after treatment for SCC of the skin. You’ll find the self-care that dermatologists recommend at, Squamous cell carcinoma of the skin: Self-care.
Alam M, Armstrong A, et al. “Guidelines of care for the management of cutaneous squamous cell carcinoma.” J Am Acad Dermatol 2018;78:560-78.
Anadolu-Brasie R, Patel AR, et al., “Squamous cell carcinoma of the skin.” In: Nouri K, et al. Skin Cancer. McGraw Hill Medical, China, 2008: 86-114.
Marrazzo G, Zitelli JA, et al. “Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.” J Am Acad Dermatol 2019;80:633-8.
Que SKT, Zwald FO, et al. “Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.” J Am Acad Dermatol 2018;78:249-61.
Ribero S, Stucci LS, et al. “Drug therapy of advanced cutaneous squamous cell carcinoma: Is there any evidence?” Curr Opin Oncol. 2017;29(2):129-35.
U.S. Food and Drug Administration. “FDA approves cemiplimab-rwlc for metastatic or locally advanced cutaneous squamous cell carcinoma.” New release issued 9/28/2018. Last accessed 1/13/2020.
Vaidya P, Mehta A, et al. “Concurrent radiation therapy with programmed cell death protein 1 inhibition leads to a complete response in advanced cutaneous squamous cell carcinoma.” JAAD Case Rep. 2019; 5(9): 763–6.
All content solely developed by the American Academy of Dermatology